Written by
Şevval T
Şevval T Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Muhammet Ali Varkal Liv Hospital Ulus Assoc. Prof. MD. Muhammet Ali Varkal Pediatrics Spec. MD. Gizem Güvener Liv Hospital Ulus Spec. MD. Gizem Güvener Pediatrics Spec. MD. Osman Karlı Liv Hospital Ulus Spec. MD. Osman Karlı Pediatrics Spec. MD. Tamer Ünver Liv Hospital Ulus Spec. MD. Tamer Ünver Neonatal Intensive Care Unit (NICU) Assoc. Prof. MD. Adem Dursun Liv Hospital Vadistanbul Assoc. Prof. MD. Adem Dursun Pediatrics Psyc. Selenay Yücel Keleş Liv Hospital Vadistanbul Psyc. Selenay Yücel Keleş Pediatric Psychology Spec. MD.  Fatih Aydın Liv Hospital Vadistanbul Spec. MD. Fatih Aydın Pediatrics Spec. MD. Dicle Çelik Liv Hospital Vadistanbul Spec. MD. Dicle Çelik Pediatrics Spec. MD. Elif Erdem Özcan Liv Hospital Vadistanbul Spec. MD. Elif Erdem Özcan Pediatrics Spec. MD. Hilal Kızıldağ Liv Hospital Vadistanbul Spec. MD. Hilal Kızıldağ Pediatrics Spec. MD. Mehmet Kılıç Liv Hospital Vadistanbul Spec. MD. Mehmet Kılıç Pediatrics Spec. MD. Ozan Uzunhan Liv Hospital Vadistanbul Spec. MD. Ozan Uzunhan Neonatology Spec. MD. Selami Bayrakdar Liv Hospital Vadistanbul Spec. MD. Selami Bayrakdar Pediatrics Spec. MD. Semra Akkuş Akman Liv Hospital Vadistanbul Spec. MD. Semra Akkuş Akman Pediatrics Asst. Prof. MD. Doruk Gül Liv Hospital Bahçeşehir Asst. Prof. MD. Doruk Gül Pediatric Health and Diseases Prof. MD. Murat Sütçü Liv Hospital Bahçeşehir Prof. MD. Murat Sütçü Pediatric Health and Diseases Prof. MD. Nihat Demir Liv Hospital Bahçeşehir Prof. MD. Nihat Demir Pediatrics Psyc. (Psychologist) Buse Yağmur Liv Hospital Bahçeşehir Psyc. (Psychologist) Buse Yağmur Pediatric Psychology Spec. MD. Cansu Muluk Liv Hospital Bahçeşehir Spec. MD. Cansu Muluk Pediatrics Spec. MD. Dilek Hatipoğlu Liv Hospital Bahçeşehir Spec. MD. Dilek Hatipoğlu Pediatric Health and Diseases Spec. MD. Duygu Amine Garavi Liv Hospital Bahçeşehir Spec. MD. Duygu Amine Garavi Pediatrics Spec. MD. Fatih Kaya Liv Hospital Bahçeşehir Spec. MD. Fatih Kaya Pediatric Health and Diseases Spec. MD. Günel Nüsretzade Elmar Liv Hospital Bahçeşehir Spec. MD. Günel Nüsretzade Elmar Pediatrics Spec. MD. Mey Talip Liv Hospital Bahçeşehir Spec. MD. Mey Talip Pediatric Intensive Care Spec. MD. Negın Nahanmoghaddam Liv Hospital Bahçeşehir Spec. MD. Negın Nahanmoghaddam Pediatrics Spec. MD. Nushaba Abdullayeva Liv Hospital Bahçeşehir Spec. MD. Nushaba Abdullayeva Pediatric Health and Diseases Spec. MD. Refika İlbakan Hanımeli Liv Hospital Bahçeşehir Spec. MD. Refika İlbakan Hanımeli Pediatrics Spec. MD. Selman Alazab Liv Hospital Bahçeşehir Spec. MD. Selman Alazab Pediatrics Spec. MD. Özden Durmuş Gönültaş Liv Hospital Bahçeşehir Spec. MD. Özden Durmuş Gönültaş Pediatrics Spec. Md. Öznur Ceylan Liv Hospital Bahçeşehir Spec. Md. Öznur Ceylan Pediatric Health and Diseases Assoc. Prof. MD. Aslan Yılmaz Liv Hospital Topkapı Assoc. Prof. MD. Aslan Yılmaz Neonatology Prof. MD. Alpay Çakmak Liv Hospital Topkapı Prof. MD. Alpay Çakmak Pediatrics Spec. MD. Demet Deniz Bilgin Liv Hospital Topkapı Spec. MD. Demet Deniz Bilgin Pediatrics Spec. MD. Nesrin Köseoğlu Liv Hospital Topkapı Spec. MD. Nesrin Köseoğlu Pediatric and Adolescent Psychiatry Spec. MD. Seçil Sözen Liv Hospital Topkapı Spec. MD. Seçil Sözen Pediatrics Spec. MD. Özge Akça Liv Hospital Topkapı Spec. MD. Özge Akça Pediatrics Spec. MD. Şeyma Öz Liv Hospital Topkapı Spec. MD. Şeyma Öz Pediatrics Asst. Prof. MD. Pakize Elif Alkış Liv Hospital Ankara Asst. Prof. MD. Pakize Elif Alkış Pediatrics Prof. MD. Musa Kazım Çağlar Liv Hospital Ankara Prof. MD. Musa Kazım Çağlar Pediatrics Prof. MD. İbrahim Hakan Bucak Liv Hospital Ankara Prof. MD. İbrahim Hakan Bucak Pediatrics Prof.MD. Sevgi Başkan Liv Hospital Ankara Prof.MD. Sevgi Başkan Pediatrics Spec. MD. Büşra Süzen Celbek Liv Hospital Ankara Spec. MD. Büşra Süzen Celbek Pediatrics Spec. MD. Galip Erdem Liv Hospital Ankara Spec. MD. Galip Erdem Pediatrics Spec. MD. Hafsa Uçur Liv Hospital Ankara Spec. MD. Hafsa Uçur Pediatric Health and Diseases Spec. MD. Hidayet Katipoğlu Liv Hospital Ankara Spec. MD. Hidayet Katipoğlu Pediatric Health and Diseases Spec. MD. Hüsniye Altan Liv Hospital Ankara Spec. MD. Hüsniye Altan Pediatrics Spec. MD. Mehmet Turfanda Liv Hospital Ankara Spec. MD. Mehmet Turfanda Pediatric Health and Diseases Spec. MD. Mustafa Yücel Kızıltan Liv Hospital Ankara Spec. MD. Mustafa Yücel Kızıltan Pediatrics Spec. MD.  Seral Navdar Liv Hospital Gaziantep Spec. MD. Seral Navdar Pediatric Health and Diseases Spec. MD. Gül Balyemez Liv Hospital Gaziantep Spec. MD. Gül Balyemez Pediatric Health and Diseases Spec. MD. Hasan Avşar Liv Hospital Gaziantep Spec. MD. Hasan Avşar Neonatology Spec. MD. Mert Çakır Liv Hospital Gaziantep Spec. MD. Mert Çakır Pediatrics Spec. MD. Saltuk Buğra Böke Liv Hospital Gaziantep Spec. MD. Saltuk Buğra Böke Pediatric Health and Diseases Spec. MD. Özlem Karaoğlu Liv Hospital Gaziantep Spec. MD. Özlem Karaoğlu Pediatric Health and Diseases Spec. MD. İsmail Ersan Can Liv Hospital Gaziantep Spec. MD. İsmail Ersan Can Pediatric Health and Diseases Spec. MD. Şekibe Zehra Doğan Liv Hospital Gaziantep Spec. MD. Şekibe Zehra Doğan Pediatric Health and Diseases Spec. MD. Gülsenem Sarı Aracı Liv Hospital Samsun Spec. MD. Gülsenem Sarı Aracı Pediatric Health and Diseases Spec. MD. Nazlı Karakullukcu Çebi Liv Hospital Samsun Spec. MD. Nazlı Karakullukcu Çebi Pediatrics Spec. MD. Nezih Akgün Liv Hospital Samsun Spec. MD. Nezih Akgün Pediatric Health and Diseases Spec. MD. Pelin Aytaç Uras Liv Hospital Samsun Spec. MD. Pelin Aytaç Uras Pediatrics MD. VEFA İSAYEVA Liv Bona Dea Hospital Bakü MD. VEFA İSAYEVA Pediatric Health and Diseases Spec. MD.  Elnur Hüseynov Liv Bona Dea Hospital Bakü Spec. MD. Elnur Hüseynov Pediatrics Spec. MD. INARE ELDAROVA Liv Bona Dea Hospital Bakü Spec. MD. INARE ELDAROVA Pediatrics Spec. MD. SADİQ İSMAYILOV Liv Bona Dea Hospital Bakü Spec. MD. SADİQ İSMAYILOV Pediatric Health and Diseases MD. Dr. Elnur Hüseynov MD. Dr. Elnur Hüseynov Pediatrics Spec. MD. Doğa Sevinçok Spec. MD. Doğa Sevinçok Pediatric and Adolescent Psychiatry Spec. MD. Sadık İsmayılov Pediatrics Spec. MD. Melike Akar Liv Hospital Bahçeşehir + Liv Hospital Topkapı Spec. MD. Melike Akar Pediatrics
...
Views
Read Time
...
views
Read Time
Wilms Tumor: How a Child Develops This Cancer
Wilms Tumor: How a Child Develops This Cancer 3

Did you know that Wilms tumor, also known as Wilms nephroblastoma, is a common childhood kidney cancer? It strikes about 1 in 10,000 kids, usually between 3 and 4 years old. Our aim is to provide guidance and support during this challenging time.

We offer top-notch healthcare for patients from around the world. We know how vital support and cutting-edge treatments are. In this piece, we’ll dive into what causes Wilms tumor, its signs, and how it’s treated. We aim to give you the info you need to make smart choices.

Key Takeaways

  • Wilms tumor is a rare type of kidney cancer that affects children.
  • The exact cause of Wilms tumor is not fully understood, but genetics are involved.
  • Symptoms include swelling, pain, or blood in the urine.
  • Treatment depends on the tumor’s stage and how severe it is.
  • Advanced treatments and full support are ready for international patients.

What is Wilms Tumor?

image 27152 LIV Hospital
Wilms Tumor: How a Child Develops This Cancer 4

Wilms tumor, also known as nephroblastoma, is a rare kidney cancer that mainly hits kids. The National Cancer Institute says it mostly affects children under 7. We’ll look into what it is, its medical terms, how common it is, and who it usually affects.

Definition and Medical Terminology

Wilms tumor is a cancer of the kidney that starts in immature cells. The term “nephroblastoma” is another name for it, showing it comes from early kidney cells. Early diagnosis is key for the best treatment and results.

Quick action is vital to tell it apart from other belly issues.

Incidence and Age Distribution

Wilms tumor is quite rare, making up about 6% of all childhood cancers. It happens in about 8 cases per million kids under 15 each year. The most common age for diagnosis is between 3 and 4, with most cases before 7.

The age when Wilms tumor is diagnosed is key. Kids under 7 are at the biggest risk, and regular check-ups help catch it early. The American Cancer Society says, “Finding Wilms tumor early greatly boosts treatment success.”

Disruptions in kidney development are linked to Wilms tumor. Knowing how this happens helps us understand and prevent this childhood cancer.

Normal Kidney Development

Kidney development is complex and involves many genes and cells. It starts early in the embryo and goes through fetal growth. The metanephric mesenchyme and the ureteric bud are key in making the kidney work.

The kidney’s growth is tightly controlled. Genes and the environment play big roles. Any problems during this time can cause Wilms tumor.

Developmental Disruptions Leading to Tumor Formation

Wilms tumor can form if kidney development goes wrong. This can be due to genetic changes, environmental factors, or both. The wilms tumor causes are complex, with genetics and environment playing parts.

Developmental StageNormal DevelopmentPotential Disruption
Early EmbryogenesisFormation of metanephric mesenchymeGenetic mutations affecting mesenchyme development
Fetal DevelopmentDifferentiation of renal cellsEnvironmental exposures affecting cellular differentiation
Late Fetal DevelopmentMaturation of kidney structuresDisruptions leading to abnormal cell proliferation

Understanding how Wilms tumor develops is key. It helps us find better treatments and ways to prevent it.

Recent studies have uncovered the genetic causes of Wilms tumor. They show a mix of genetic and epigenetic factors at play. Knowing these factors helps us find children at risk and create better treatments.

WT1 Gene Mutations

The WT1 gene is key in kidney growth. Mutations in this gene link to Wilms tumor. The WT1 gene stops tumor growth, but its mutation causes cells to grow out of control. About 10-15% of Wilms tumors have WT1 mutations.

WT2 Gene and Other Genetic Alterations

Other genes also play a part in Wilms tumor. The WT2 gene is involved, but its role is not as clear as WT1. Changes in genes that control cell growth and DNA repair also help tumors grow.

Epigenetic Factors

Epigenetic changes affect how genes work. In Wilms tumor, these changes can turn off genes that stop tumors or turn on genes that cause them. Studying these changes helps us understand how tumors form and find new treatments.

The genetics of Wilms tumor are complex, with many genetic and epigenetic changes involved. More research is needed to find better treatments and improve patient care.

Inherited Predisposition to Wilms Tumor

Understanding the inherited predisposition to Wilms tumor is key to spotting families at risk. Most Wilms tumors happen by chance, but a big part happens in families. This shows a strong link between family history and the disease.

Familial Wilms Tumor Patterns

About 1-2% of Wilms tumors are linked to family history. These cases often follow an autosomal dominant pattern. This means just one mutated gene can raise the risk of getting the tumor.

Research has found several genes linked to familial Wilms tumor. This shows how complex its genetics are.

Studies show families with Wilms tumor history are more likely to have more cases. Genetic screening and watching for signs are advised for family members. This is true, more so if there’s a clear family pattern.

Genetic counseling is vital for families with Wilms tumor. Counselors help families grasp the risk of Wilms tumor in other family members. They also talk about genetic testing and watching for signs.

A genetic counselor can explain what a genetic diagnosis means. They help families make informed choices about their health. For families with Wilms tumor history, counseling offers insights into recurrence risk and early detection benefits.

Family HistoryRisk AssessmentRecommended Surveillance
No known family historyLow to moderate riskRoutine monitoring
First-degree relative with Wilms tumorModerate to high riskRegular ultrasound screening
Multiple family members with Wilms tumorHigh riskIntensive surveillance and genetic testing

Genetic counseling and testing help spot at-risk individuals. This leads to early action.

Associated Genetic Syndromes

Many genetic syndromes increase the risk of Wilms tumor. Knowing about these syndromes helps in early detection and treatment.

WAGR Syndrome

WAGR syndrome is a rare genetic disorder. It’s caused by a deletion on chromosome 11p13. This syndrome greatly increases the risk of Wilms tumor, with up to 50% of children affected.

Denys-Drash Syndrome

Denys-Drash syndrome also raises the risk of Wilms tumor. It’s caused by WT1 gene mutations. The syndrome is rare but significantly increases the risk of Wilms tumor.

Beckwith-Wiedemann Syndrome

Beckwith-Wiedemann syndrome is an overgrowth disorder. It increases the risk of tumors, including Wilms tumor. Children with this syndrome need regular checks for Wilms tumor and other tumors.

Other Related Syndromes

Other genetic conditions also raise the risk of Wilms tumor. These include WT1 gene mutations and other genetic changes that affect kidney development. Knowing about these can help in early detection and management of Wilms tumor.

It’s important to recognize genetic syndromes linked to Wilms tumor. This knowledge helps in providing the right care and surveillance for affected children. Healthcare providers can then offer targeted screening and early intervention, which can improve outcomes for children at risk.

Environmental Risk Factors for Wilms Tumor

Wilms tumor has many causes, with both genetics and environment playing big roles. We don’t always know what causes it, but studying these factors helps us find ways to prevent it. It also helps us improve treatments.

Prenatal Exposures

Research has shown that what a mother is exposed to before birth can affect her child’s risk of Wilms tumor. Studies have found links between certain toxins, chemicals, and diet during pregnancy and a higher risk. But, we need more research to confirm these findings.

Parental Occupational Exposures

Jobs that involve chemicals or dangerous materials have also been studied. Exposure to chemicals by fathers has been linked to a higher risk of Wilms tumor in their kids. But, we don’t fully understand how this happens and need more research.

Other Environmental Triggers

Other things that might trigger Wilms tumor include radiation, infections, and the environment around birth. Some studies have found possible links, but we need more evidence. This will help us understand how these factors contribute to Wilms tumor.

In summary, Ongoing research continues to shed light on the causes of Wilms tumor. By studying prenatal exposures, parental jobs, and other environmental factors, we can work on prevention and early detection.

Knowing the signs of Wilms tumor is key for early treatment. This cancer mainly hits kids. It’s also known as nephroblastoma.

Common Presenting Symptoms

  • Abdominal Mass: A common sign is a noticeable belly mass. Parents or doctors often find it during a check-up.
  • Abdominal Pain: Some kids might feel belly pain or discomfort. This could be because the tumor is growing or has burst.
  • Hematuria: Seeing blood in the urine is another symptom. It happens in many cases.
  • Hypertension: High blood pressure can also be a sign. It’s caused by the tumor’s impact on the kidneys or by pressing on blood vessels.

Physical Examination Findings

Doctors might find:

  • A firm, non-tender belly mass that’s quite big.
  • Signs of anemia or weight loss in more serious cases.
  • Hypertension, which needs careful management.

Asymptomatic Presentation

Some kids with Wilms tumor don’t show symptoms. The tumor might be found by chance during tests for something else. This shows why it’s important to check any belly issues closely.

In summary, spotting Wilms tumor signs early is critical. Doctors need to know about different symptoms to help kids with this disease.

Diagnostic Approach to Wilms Tumor

To accurately diagnose Wilms Tumor, we use a detailed strategy. This includes imaging and lab tests. Our goal is to diagnose this condition effectively.

Imaging Studies

Imaging studies are key in diagnosing Wilms Tumor. Ultrasound is often the first choice because it’s non-invasive. It helps find the tumor’s location and size.

Computed Tomography (CT) scans give more detailed info. They show how big the tumor is and if it has spread. MRI might also be used to check the tumor’s details and how it affects nearby areas.

These imaging tests are vital for understanding the tumor’s stage. They help us plan the best treatment.

Laboratory Investigations

Laboratory tests are also important. Blood tests check overall health and look for tumor signs. Urine tests check for kidney problems.

Tumor markers might be tested to tell Wilms Tumor apart from other masses. Genetic markers are used to find related genetic syndromes.

Biopsy Considerations

A biopsy is needed to confirm Wilms Tumor. Fine-needle aspiration biopsy or core needle biopsy gets tissue for examination. The biopsy results are key for treatment planning.

We choose the biopsy method carefully. This ensures accurate diagnosis and safety for the patient. The findings from imaging, lab tests, and biopsy guide our treatment plan for Wilms Tumor.

Understanding the Wilms Tumor Staging System

Wilms tumor staging is key in figuring out how far the disease has spread. It helps doctors plan the best treatment for each patient. This system is important for knowing how well a patient might do.

Stage I: Confined to Kidney

Stage I Wilms tumor is found only in the kidney and is fully removed. The tumor doesn’t spread outside the kidney. This makes the disease easier to treat and gives patients a better chance of recovery.

Stage II: Beyond Kidney but Completely Resected

Stage II means the tumor grows beyond the kidney but is removed during surgery. The tumor might touch nearby areas like the renal sinus. But, it’s all taken out, which is good news for the patient.

Stage III: Residual Abdominal Disease

Stage III shows there’s leftover disease in the belly after surgery. This could be in lymph nodes, from spillage, or as implants. More treatment, like chemo or radiation, is needed to get rid of the remaining cancer.

Stage IV: Hematogenous Metastases

Stage IV means the tumor has spread to distant places like the lungs, liver, or bones. This is a tougher case. It needs strong treatments like chemotherapy and sometimes radiation to fight the spread.

Getting the right stage for Wilms tumor is very important. It helps doctors choose the best treatment and gives a better idea of how the patient will do. The staging system helps everyone involved in the patient’s care to work together effectively.

StageDescriptionPrognosis
Stage ITumor confined to kidney, completely resectedFavorable
Stage IITumor beyond kidney, completely resectedGenerally favorable
Stage IIIResidual abdominal diseaseVariable, depends on residual disease extent
Stage IVHematogenous metastasesMore challenging, requires aggressive treatment

Knowing the histological features of Wilms tumor is key to managing it well. The classification helps predict the outcome and shapes treatment plans.

Favorable Histology

Wilms tumors with favorable histology have blastema, epithelia, and stroma. These tumors usually have a better outlook than those with anaplastic features. This type of tumor often responds well to surgery and chemotherapy.

Anaplastic Histology

Anaplastic Wilms tumor shows anaplastic cells that are bigger and more irregular. Anaplasia can be focal or diffuse, with diffuse being worse. Finding anaplastic histology is important because it often means the tumor won’t respond to chemotherapy well.

Prognostic Implications

The type of Wilms tumor affects its prognosis. Tumors with favorable histology have a great chance of recovery with the right treatment. But, anaplastic tumors are harder to treat and need more aggressive therapy.

Understanding the histological classification is not just for treatment planning. It also gives insight into what to expect for patients. By knowing the specific features of Wilms tumor, doctors can make treatment plans that improve patient results.

Bilateral Wilms Tumor: Special Considerations

Managing bilateral Wilms tumor needs a deep understanding of its genetic roots and clinical aspects. This type of tumor affects about 5-7% of cases. It brings unique challenges in diagnosis, treatment, and long-term care.

Genetic Associations

Bilateral Wilms tumor often comes with genetic predispositions. Mutations in the WT1 gene are common. Patients with this tumor are more likely to have genetic syndromes like WAGR or Denys-Drash, linked to WT1 mutations.

Knowing these genetic links is key to effective management. Genetic tests can spot mutations that guide treatment and predict other conditions.

Treatment Challenges

Treating bilateral Wilms tumor is complex. It’s a balance between fighting cancer and saving kidney function. The main challenge is reducing tumors without harming the kidneys.

Doctors use chemotherapy, surgery, and sometimes radiation. The aim is to shrink or remove tumors in both kidneys, keeping as much kidney function as possible.

Treatment ApproachObjectiveConsiderations
ChemotherapyReduce tumor sizePotential toxicity, impact on kidney function
SurgeryRemove tumors, preserve kidney tissueRisk of surgical complications, impact on renal function
Radiation TherapyControl residual diseaseRisk of radiation-induced damage to surrounding tissues

Kidney-Preserving Approaches

Kidney-preserving strategies are vital for bilateral Wilms tumor. Techniques like partial nephrectomy and tumor enucleation aim to remove tumors while saving kidney tissue.

These methods need careful planning and execution for the best results. Advanced imaging and intraoperative ultrasound help in precise tumor removal.

By combining genetic insights, advanced surgery, and careful planning, we can better help patients with bilateral Wilms tumor.

Differentiating Wilms Tumor from Other Childhood Cancers

Diagnosing Wilms tumor can be tricky because it looks like other tumors in kids’ bellies. Getting it right is key to treating it well.

Neuroblastoma Comparison

Neuroblastoma is another common tumor in kids, often seen as a belly mass. It comes from the nervous system, unlike Wilms tumor which comes from the kidney. The main differences are:

  • Origin: Wilms tumor starts in the kidney, while neuroblastoma comes from the nervous system.
  • Age of presentation: Neuroblastoma shows up earlier than Wilms tumor.
  • Biological markers: Neuroblastoma has high levels of certain chemicals.

Renal Cell Carcinoma in Children

Renal cell carcinoma (RCC) is rare in kids and makes up a small part of kidney tumors in them. It’s hard to tell RCC from Wilms tumor because they look similar. But, there are some clues:

CharacteristicsWilms TumorRenal Cell Carcinoma
AgeTypically under 5 yearsMore common in older kids and teens
HistologyHas a mix of three types (blastema, epithelia, stroma)Looks like adult RCC, with different types

Other Abdominal Masses

Other belly masses that might look like Wilms tumor include:

  • Hepatic tumors
  • Lymphoma
  • Rhabdomyosarcoma
  • Other rare kidney or back-of-the-belly tumors

A top pediatric oncologist says, “Diagnosing an abdominal mass in a child is wide-ranging and needs a detailed approach to find out what tumor it is.”

“The process includes imaging, lab tests, and looking at tissue samples to correctly diagnose and treat these complex tumors.”

We stress the need for a team effort in diagnosing and treating childhood cancers. This ensures each child gets the best care for their unique situation.

Treatment Strategies for Wilms Tumor

Wilms tumor treatment involves surgery, chemotherapy, and sometimes radiation. Each patient gets a treatment plan that fits their needs.

Surgical Approaches

Surgery is key in treating Wilms tumor. The goal is to remove the tumor completely. Radical nephrectomy is common, removing the kidney and tumor. Sometimes, nephron-sparing surgery is used to save the kidney, mainly in bilateral cases.

Chemotherapy Protocols

Chemotherapy is vital in treating Wilms tumor. It makes the tumor smaller before surgery and kills any cancer cells left after. The main drugs used are vincristine, dactinomycin, and doxorubicin. The treatment plan depends on the tumor’s stage and type.

Radiation Therapy Indications

In some cases, radiation therapy is used for Wilms tumor. It’s mainly for advanced disease or certain tumor types. The choice to use radiation depends on the tumor’s stage, type, and how it responds to chemotherapy.

Novel Targeted Therapies

Researchers are working on new treatments for Wilms tumor. Targeted therapy aims to be more effective with fewer side effects. Tyrosine kinase inhibitors are being tested in clinical trials for Wilms tumor treatment.

Treatment ModalityIndicationsKey Components
SurgeryPrimary treatment for localized diseaseRadical nephrectomy, nephron-sparing surgery
ChemotherapyPre-operative and post-operative treatmentVincristine, dactinomycin, doxorubicin
Radiation TherapyAdvanced disease, unfavorable histologyExternal beam radiation
Targeted TherapyOngoing clinical trials, specific genetic mutationsTyrosine kinase inhibitors

Survival Rates and Long-term Prognosis

Children with Wilms tumor now have a better chance of survival thanks to new treatments. These advancements have greatly improved their chances of beating the disease. This progress is thanks to the hard work of doctors and researchers working together.

Factors Influencing Survival

Several things can affect how well a child with Wilms tumor will do. Age at diagnosis is very important; younger kids usually do better. The stage of the disease at the start also matters a lot. Plus, the histological classification of the tumor, whether it’s favorable or anaplastic, impacts treatment and results.

  • Age at diagnosis
  • Stage of the disease
  • Histological classification

Stage-Specific Outcomes

The stage of Wilms tumor at diagnosis is key to knowing the outcome. Stage I tumors, which only affect the kidney, have a great chance of recovery with the right treatment. On the other hand, Stage IV tumors, which have spread to other parts of the body, need more aggressive treatment and have a tougher road ahead. Knowing the stage helps doctors plan the best treatment.

  1. Stage I: Confined to the kidney
  2. Stage II: Beyond the kidney but completely resected
  3. Stage III: Residual abdominal disease
  4. Stage IV: Hematogenous metastases

Recurrence Patterns

Recurrence is a big worry in treating Wilms tumor. The type of recurrence, whether it’s local or distant, guides the treatment plan. Local recurrence happens when the tumor comes back in the same place. Metastatic recurrence is when it spreads to other places like the lungs or liver. Knowing these patterns helps in planning follow-up and treatment.

“The management of recurrent Wilms tumor requires a thorough approach, including surgery, chemotherapy, and sometimes radiation therapy.”

— Expert in Pediatric Oncology

By looking at what affects survival, stage-specific outcomes, and recurrence patterns, we can understand Wilms tumor better. This knowledge helps doctors give more tailored and effective care to patients.

Late Effects and Survivorship Issues

Survivors of Wilms tumor face challenges beyond treatment. They may deal with late effects that need careful management. As survival rates improve, tackling these long-term health issues is key.

Renal Function Monitoring

One major late effect is renal dysfunction. Survivors who had a kidney removed or got certain chemo are at risk. It’s vital to watch their kidney function closely.

Renal Function Tests should be done every year. These include checking serum creatinine levels and urine protein. This helps spot early signs of chronic kidney disease.

Renal Function TestFrequencyPurpose
Serum CreatinineAnnuallyAssess kidney function
Urine Protein CheckAnnuallyDetect proteinuria
GFR CalculationAnnuallyEstimate glomerular filtration rate

Secondary Malignancies

Survivors of Wilms tumor face a higher risk of getting other cancers, mainly if they had radiation therapy. This highlights the need for ongoing care.

They should get regular check-ups, imaging when needed, and learn to report new symptoms.

Growth and Development Concerns

Treatment for Wilms tumor can affect growth and development, more so in young kids. It can lead to musculoskeletal issues or scoliosis, if they had radiation.

It’s important for a team of specialists to regularly check on these survivors. This includes orthopedic and rehab experts.

Fertility Considerations

Wilms tumor treatment can also impact fertility. Those who got certain chemo or abdominal radiation are at higher risk.

Talking about fertility options before treatment is key. Survivors need counseling on reproductive health and fertility preservation strategies.

By understanding and managing these late effects, healthcare providers can give Wilms tumor survivors the care they need. This helps them live a better life as they grow into adulthood.

Conclusion

Understanding Wilms tumor is key to giving kids the best care when they’re diagnosed. Our summary shows how early detection and accurate diagnosis are vital. It also highlights the importance of effective treatment plans. Important points about Wilms tumor include the role of genetics and the use of imaging in diagnosis. A team approach to treatment is also critical. We focus on the need for support for patients and their families around the world. Our conclusion stresses the need for ongoing research into Wilms tumor. It’s also important to provide top-notch healthcare with full support services. We’re dedicated to giving the best care to kids with Wilms tumor and their families everywhere.

FAQ

What is Wilms tumor?

Wilms tumor, also known as nephroblastoma, is a rare kidney cancer. It usually affects children under 7.

What are the common symptoms of Wilms tumor?

Symptoms include swelling or pain in the abdomen, fever, and blood in the urine. Some cases have no symptoms at all.

Ongoing research continues to shed light on the causes of Wilms tumor.

It starts from tissues in the early stages of kidney development. Genetic and epigenetic factors play a role. This includes mutations in the WT1 gene.

Is Wilms tumor hereditary?

Yes, it can run in families. Genetic counseling is advised for families with a history of the disease. Syndromes like WAGR and Beckwith-Wiedemann increase the risk.

How is Wilms tumor diagnosed?

Diagnosis uses imaging like ultrasound and CT scans. Blood tests and urine analysis are also part of the process. A biopsy may confirm the diagnosis.

What is the Wilms tumor staging system?

The system ranges from Stage I (confined to the kidney) to Stage IV (with distant spread). Accurate staging is key for treatment planning.

What are the treatment options for Wilms tumor?

Treatments include surgery, chemotherapy, and sometimes radiation. New targeted therapies are being researched.

What is the prognosis for Wilms tumor?

Survival rates depend on the tumor’s stage and type. Anaplasia and treatment effectiveness also play a role.

What are the late effects of Wilms tumor treatment?

Survivors might face kidney problems, cancer, growth issues, and fertility problems. Long-term care is vital for managing these effects.

Yes, it can recur. The risk depends on the tumor’s stage and type. Regular check-ups are needed to catch any recurrence.

Are there any genetic syndromes associated with Wilms tumor?

Yes, syndromes like WAGR and Beckwith-Wiedemann increase the risk of Wilms tumor.

How does bilateral Wilms tumor affect treatment?

Bilateral tumors pose unique challenges. Kidney-preserving treatments may be considered to maintain function.

References

  • Green, D. M., et al. (2009). Early and late mortality after diagnosis of Wilms tumor. Journal of Clinical Oncology, 27(1), 112-119. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667828/
  • National Cancer Institute. (2025). Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®)–Patient Version. https://www.cancer.gov/types/kidney/hp/wilms-treatment-pdq
  • Gailani, M., et al. (2022). Multidisciplinary treatment strategies for Wilms tumor: Recent advances, technical innovations and future directions. Frontiers in Pediatrics, 10, 852185. https://www.frontiersin.org/articles/10.3389/fped.2022.852185/full
i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR

Related Doctors

Assoc. Prof. MD. Muhammet Ali Varkal Liv Hospital Ulus Assoc. Prof. MD. Muhammet Ali Varkal Pediatrics Spec. MD. Gizem Güvener Liv Hospital Ulus Spec. MD. Gizem Güvener Pediatrics Spec. MD. Osman Karlı Liv Hospital Ulus Spec. MD. Osman Karlı Pediatrics Spec. MD. Tamer Ünver Liv Hospital Ulus Spec. MD. Tamer Ünver Neonatal Intensive Care Unit (NICU) Assoc. Prof. MD. Adem Dursun Liv Hospital Vadistanbul Assoc. Prof. MD. Adem Dursun Pediatrics Psyc. Selenay Yücel Keleş Liv Hospital Vadistanbul Psyc. Selenay Yücel Keleş Pediatric Psychology Spec. MD.  Fatih Aydın Liv Hospital Vadistanbul Spec. MD. Fatih Aydın Pediatrics Spec. MD. Dicle Çelik Liv Hospital Vadistanbul Spec. MD. Dicle Çelik Pediatrics Spec. MD. Elif Erdem Özcan Liv Hospital Vadistanbul Spec. MD. Elif Erdem Özcan Pediatrics Spec. MD. Hilal Kızıldağ Liv Hospital Vadistanbul Spec. MD. Hilal Kızıldağ Pediatrics Spec. MD. Mehmet Kılıç Liv Hospital Vadistanbul Spec. MD. Mehmet Kılıç Pediatrics Spec. MD. Ozan Uzunhan Liv Hospital Vadistanbul Spec. MD. Ozan Uzunhan Neonatology Spec. MD. Selami Bayrakdar Liv Hospital Vadistanbul Spec. MD. Selami Bayrakdar Pediatrics Spec. MD. Semra Akkuş Akman Liv Hospital Vadistanbul Spec. MD. Semra Akkuş Akman Pediatrics Asst. Prof. MD. Doruk Gül Liv Hospital Bahçeşehir Asst. Prof. MD. Doruk Gül Pediatric Health and Diseases Prof. MD. Murat Sütçü Liv Hospital Bahçeşehir Prof. MD. Murat Sütçü Pediatric Health and Diseases Prof. MD. Nihat Demir Liv Hospital Bahçeşehir Prof. MD. Nihat Demir Pediatrics Psyc. (Psychologist) Buse Yağmur Liv Hospital Bahçeşehir Psyc. (Psychologist) Buse Yağmur Pediatric Psychology Spec. MD. Cansu Muluk Liv Hospital Bahçeşehir Spec. MD. Cansu Muluk Pediatrics Spec. MD. Dilek Hatipoğlu Liv Hospital Bahçeşehir Spec. MD. Dilek Hatipoğlu Pediatric Health and Diseases Spec. MD. Duygu Amine Garavi Liv Hospital Bahçeşehir Spec. MD. Duygu Amine Garavi Pediatrics Spec. MD. Fatih Kaya Liv Hospital Bahçeşehir Spec. MD. Fatih Kaya Pediatric Health and Diseases Spec. MD. Günel Nüsretzade Elmar Liv Hospital Bahçeşehir Spec. MD. Günel Nüsretzade Elmar Pediatrics Spec. MD. Mey Talip Liv Hospital Bahçeşehir Spec. MD. Mey Talip Pediatric Intensive Care Spec. MD. Negın Nahanmoghaddam Liv Hospital Bahçeşehir Spec. MD. Negın Nahanmoghaddam Pediatrics Spec. MD. Nushaba Abdullayeva Liv Hospital Bahçeşehir Spec. MD. Nushaba Abdullayeva Pediatric Health and Diseases Spec. MD. Refika İlbakan Hanımeli Liv Hospital Bahçeşehir Spec. MD. Refika İlbakan Hanımeli Pediatrics Spec. MD. Selman Alazab Liv Hospital Bahçeşehir Spec. MD. Selman Alazab Pediatrics Spec. MD. Özden Durmuş Gönültaş Liv Hospital Bahçeşehir Spec. MD. Özden Durmuş Gönültaş Pediatrics Spec. Md. Öznur Ceylan Liv Hospital Bahçeşehir Spec. Md. Öznur Ceylan Pediatric Health and Diseases Assoc. Prof. MD. Aslan Yılmaz Liv Hospital Topkapı Assoc. Prof. MD. Aslan Yılmaz Neonatology Prof. MD. Alpay Çakmak Liv Hospital Topkapı Prof. MD. Alpay Çakmak Pediatrics Spec. MD. Demet Deniz Bilgin Liv Hospital Topkapı Spec. MD. Demet Deniz Bilgin Pediatrics Spec. MD. Nesrin Köseoğlu Liv Hospital Topkapı Spec. MD. Nesrin Köseoğlu Pediatric and Adolescent Psychiatry Spec. MD. Seçil Sözen Liv Hospital Topkapı Spec. MD. Seçil Sözen Pediatrics Spec. MD. Özge Akça Liv Hospital Topkapı Spec. MD. Özge Akça Pediatrics Spec. MD. Şeyma Öz Liv Hospital Topkapı Spec. MD. Şeyma Öz Pediatrics Asst. Prof. MD. Pakize Elif Alkış Liv Hospital Ankara Asst. Prof. MD. Pakize Elif Alkış Pediatrics Prof. MD. Musa Kazım Çağlar Liv Hospital Ankara Prof. MD. Musa Kazım Çağlar Pediatrics Prof. MD. İbrahim Hakan Bucak Liv Hospital Ankara Prof. MD. İbrahim Hakan Bucak Pediatrics Prof.MD. Sevgi Başkan Liv Hospital Ankara Prof.MD. Sevgi Başkan Pediatrics Spec. MD. Büşra Süzen Celbek Liv Hospital Ankara Spec. MD. Büşra Süzen Celbek Pediatrics Spec. MD. Galip Erdem Liv Hospital Ankara Spec. MD. Galip Erdem Pediatrics Spec. MD. Hafsa Uçur Liv Hospital Ankara Spec. MD. Hafsa Uçur Pediatric Health and Diseases Spec. MD. Hidayet Katipoğlu Liv Hospital Ankara Spec. MD. Hidayet Katipoğlu Pediatric Health and Diseases Spec. MD. Hüsniye Altan Liv Hospital Ankara Spec. MD. Hüsniye Altan Pediatrics Spec. MD. Mehmet Turfanda Liv Hospital Ankara Spec. MD. Mehmet Turfanda Pediatric Health and Diseases Spec. MD. Mustafa Yücel Kızıltan Liv Hospital Ankara Spec. MD. Mustafa Yücel Kızıltan Pediatrics Spec. MD.  Seral Navdar Liv Hospital Gaziantep Spec. MD. Seral Navdar Pediatric Health and Diseases Spec. MD. Gül Balyemez Liv Hospital Gaziantep Spec. MD. Gül Balyemez Pediatric Health and Diseases Spec. MD. Hasan Avşar Liv Hospital Gaziantep Spec. MD. Hasan Avşar Neonatology Spec. MD. Mert Çakır Liv Hospital Gaziantep Spec. MD. Mert Çakır Pediatrics Spec. MD. Saltuk Buğra Böke Liv Hospital Gaziantep Spec. MD. Saltuk Buğra Böke Pediatric Health and Diseases Spec. MD. Özlem Karaoğlu Liv Hospital Gaziantep Spec. MD. Özlem Karaoğlu Pediatric Health and Diseases Spec. MD. İsmail Ersan Can Liv Hospital Gaziantep Spec. MD. İsmail Ersan Can Pediatric Health and Diseases Spec. MD. Şekibe Zehra Doğan Liv Hospital Gaziantep Spec. MD. Şekibe Zehra Doğan Pediatric Health and Diseases Spec. MD. Gülsenem Sarı Aracı Liv Hospital Samsun Spec. MD. Gülsenem Sarı Aracı Pediatric Health and Diseases Spec. MD. Nazlı Karakullukcu Çebi Liv Hospital Samsun Spec. MD. Nazlı Karakullukcu Çebi Pediatrics Spec. MD. Nezih Akgün Liv Hospital Samsun Spec. MD. Nezih Akgün Pediatric Health and Diseases Spec. MD. Pelin Aytaç Uras Liv Hospital Samsun Spec. MD. Pelin Aytaç Uras Pediatrics MD. VEFA İSAYEVA Liv Bona Dea Hospital Bakü MD. VEFA İSAYEVA Pediatric Health and Diseases Spec. MD.  Elnur Hüseynov Liv Bona Dea Hospital Bakü Spec. MD. Elnur Hüseynov Pediatrics Spec. MD. INARE ELDAROVA Liv Bona Dea Hospital Bakü Spec. MD. INARE ELDAROVA Pediatrics Spec. MD. SADİQ İSMAYILOV Liv Bona Dea Hospital Bakü Spec. MD. SADİQ İSMAYILOV Pediatric Health and Diseases MD. Dr. Elnur Hüseynov MD. Dr. Elnur Hüseynov Pediatrics Spec. MD. Doğa Sevinçok Spec. MD. Doğa Sevinçok Pediatric and Adolescent Psychiatry Spec. MD. Sadık İsmayılov Pediatrics Spec. MD. Melike Akar Liv Hospital Bahçeşehir + Liv Hospital Topkapı Spec. MD. Melike Akar Pediatrics
Trusted Worldwide
30
Years of
Experience
30 Years Badge
Health Türkiye Accreditation

Trusted Worldwide

30 Years of Experience

Patient Reviews
Reviews from 9,651
4,9
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Muhammet Ali Varkal Pediatrics

Assoc. Prof. MD. Muhammet Ali Varkal

Liv Hospital Ulus
Spec. MD. Gizem Güvener Pediatrics

Spec. MD. Gizem Güvener

Liv Hospital Ulus
Spec. MD. Osman Karlı Pediatrics

Spec. MD. Osman Karlı

Liv Hospital Ulus
Spec. MD. Tamer Ünver Neonatal Intensive Care Unit (NICU)

Spec. MD. Tamer Ünver

Liv Hospital Ulus
Assoc. Prof. MD. Adem Dursun Pediatrics

Assoc. Prof. MD. Adem Dursun

Liv Hospital Vadistanbul
Psyc. Selenay Yücel Keleş Pediatric Psychology

Psyc. Selenay Yücel Keleş

Liv Hospital Vadistanbul
Spec. MD.  Fatih Aydın Pediatrics

Spec. MD. Fatih Aydın

Liv Hospital Vadistanbul
Spec. MD. Dicle Çelik Pediatrics

Spec. MD. Dicle Çelik

Liv Hospital Vadistanbul
Spec. MD. Elif Erdem Özcan Pediatrics

Spec. MD. Elif Erdem Özcan

Liv Hospital Vadistanbul
Spec. MD. Hilal Kızıldağ Pediatrics

Spec. MD. Hilal Kızıldağ

Liv Hospital Vadistanbul
Spec. MD. Mehmet Kılıç Pediatrics

Spec. MD. Mehmet Kılıç

Liv Hospital Vadistanbul
Spec. MD. Ozan Uzunhan Neonatology

Spec. MD. Ozan Uzunhan

Liv Hospital Vadistanbul
Spec. MD. Selami Bayrakdar Pediatrics

Spec. MD. Selami Bayrakdar

Liv Hospital Vadistanbul
Spec. MD. Semra Akkuş Akman Pediatrics

Spec. MD. Semra Akkuş Akman

Liv Hospital Vadistanbul
Asst. Prof. MD. Doruk Gül Pediatric Health and Diseases

Asst. Prof. MD. Doruk Gül

Liv Hospital Bahçeşehir
Prof. MD. Murat Sütçü Pediatric Health and Diseases

Prof. MD. Murat Sütçü

Liv Hospital Bahçeşehir
Prof. MD. Nihat Demir Pediatrics

Prof. MD. Nihat Demir

Liv Hospital Bahçeşehir
Psyc. (Psychologist) Buse Yağmur Pediatric Psychology

Psyc. (Psychologist) Buse Yağmur

Liv Hospital Bahçeşehir
Spec. MD. Cansu Muluk Pediatrics

Spec. MD. Cansu Muluk

Liv Hospital Bahçeşehir
Spec. MD. Dilek Hatipoğlu Pediatric Health and Diseases

Spec. MD. Dilek Hatipoğlu

Liv Hospital Bahçeşehir
Spec. MD. Duygu Amine Garavi Pediatrics

Spec. MD. Duygu Amine Garavi

Liv Hospital Bahçeşehir
Spec. MD. Fatih Kaya Pediatric Health and Diseases

Spec. MD. Fatih Kaya

Liv Hospital Bahçeşehir
Spec. MD. Günel Nüsretzade Elmar Pediatrics

Spec. MD. Günel Nüsretzade Elmar

Liv Hospital Bahçeşehir
Spec. MD. Melike Akar Pediatrics

Spec. MD. Melike Akar

Liv Hospital Bahçeşehir
Liv Hospital Topkapı
Spec. MD. Mey Talip Pediatric Intensive Care

Spec. MD. Mey Talip

Liv Hospital Bahçeşehir
Spec. MD. Negın Nahanmoghaddam Pediatrics

Spec. MD. Negın Nahanmoghaddam

Liv Hospital Bahçeşehir
Spec. MD. Nushaba Abdullayeva Pediatric Health and Diseases

Spec. MD. Nushaba Abdullayeva

Liv Hospital Bahçeşehir
Spec. MD. Refika İlbakan Hanımeli Pediatrics

Spec. MD. Refika İlbakan Hanımeli

Liv Hospital Bahçeşehir
Spec. MD. Selman Alazab Pediatrics

Spec. MD. Selman Alazab

Liv Hospital Bahçeşehir
Spec. MD. Özden Durmuş Gönültaş Pediatrics

Spec. MD. Özden Durmuş Gönültaş

Liv Hospital Bahçeşehir
Spec. Md. Öznur Ceylan Pediatric Health and Diseases

Spec. Md. Öznur Ceylan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Aslan Yılmaz Neonatology

Assoc. Prof. MD. Aslan Yılmaz

Liv Hospital Topkapı
Prof. MD. Alpay Çakmak Pediatrics

Prof. MD. Alpay Çakmak

Liv Hospital Topkapı
Spec. MD. Demet Deniz Bilgin Pediatrics

Spec. MD. Demet Deniz Bilgin

Liv Hospital Topkapı
Spec. MD. Nesrin Köseoğlu Pediatric and Adolescent Psychiatry

Spec. MD. Nesrin Köseoğlu

Liv Hospital Topkapı
Spec. MD. Seçil Sözen Pediatrics

Spec. MD. Seçil Sözen

Liv Hospital Topkapı
Spec. MD. Özge Akça Pediatrics

Spec. MD. Özge Akça

Liv Hospital Topkapı
Spec. MD. Şeyma Öz Pediatrics

Spec. MD. Şeyma Öz

Liv Hospital Topkapı
Asst. Prof. MD. Pakize Elif Alkış Pediatrics

Asst. Prof. MD. Pakize Elif Alkış

Liv Hospital Ankara
Prof. MD. Musa Kazım Çağlar Pediatrics

Prof. MD. Musa Kazım Çağlar

Liv Hospital Ankara
Prof. MD. İbrahim Hakan Bucak Pediatrics

Prof. MD. İbrahim Hakan Bucak

Liv Hospital Ankara
Prof.MD. Sevgi Başkan Pediatrics

Prof.MD. Sevgi Başkan

Liv Hospital Ankara
Spec. MD. Büşra Süzen Celbek Pediatrics

Spec. MD. Büşra Süzen Celbek

Liv Hospital Ankara
Spec. MD. Galip Erdem Pediatrics

Spec. MD. Galip Erdem

Liv Hospital Ankara
Spec. MD. Hafsa Uçur Pediatric Health and Diseases

Spec. MD. Hafsa Uçur

Liv Hospital Ankara
Spec. MD. Hidayet Katipoğlu Pediatric Health and Diseases

Spec. MD. Hidayet Katipoğlu

Liv Hospital Ankara
Spec. MD. Hüsniye Altan Pediatrics

Spec. MD. Hüsniye Altan

Liv Hospital Ankara
Spec. MD. Mehmet Turfanda Pediatric Health and Diseases

Spec. MD. Mehmet Turfanda

Liv Hospital Ankara
Spec. MD. Mustafa Yücel Kızıltan Pediatrics

Spec. MD. Mustafa Yücel Kızıltan

Liv Hospital Ankara
Spec. MD.  Seral Navdar Pediatric Health and Diseases

Spec. MD. Seral Navdar

Liv Hospital Gaziantep
Spec. MD. Gül Balyemez Pediatric Health and Diseases

Spec. MD. Gül Balyemez

Liv Hospital Gaziantep
Spec. MD. Hasan Avşar Neonatology

Spec. MD. Hasan Avşar

Liv Hospital Gaziantep
Spec. MD. Mert Çakır Pediatrics

Spec. MD. Mert Çakır

Liv Hospital Gaziantep
Spec. MD. Saltuk Buğra Böke Pediatric Health and Diseases

Spec. MD. Saltuk Buğra Böke

Liv Hospital Gaziantep
Spec. MD. Özlem Karaoğlu Pediatric Health and Diseases

Spec. MD. Özlem Karaoğlu

Liv Hospital Gaziantep
Spec. MD. İsmail Ersan Can Pediatric Health and Diseases

Spec. MD. İsmail Ersan Can

Liv Hospital Gaziantep
Spec. MD. Şekibe Zehra Doğan Pediatric Health and Diseases

Spec. MD. Şekibe Zehra Doğan

Liv Hospital Gaziantep
Spec. MD. Gülsenem Sarı Aracı Pediatric Health and Diseases

Spec. MD. Gülsenem Sarı Aracı

Liv Hospital Samsun
Spec. MD. Nazlı Karakullukcu Çebi Pediatrics

Spec. MD. Nazlı Karakullukcu Çebi

Liv Hospital Samsun
Spec. MD. Nezih Akgün Pediatric Health and Diseases

Spec. MD. Nezih Akgün

Liv Hospital Samsun
Spec. MD. Pelin Aytaç Uras Pediatrics

Spec. MD. Pelin Aytaç Uras

Liv Hospital Samsun
MD. VEFA İSAYEVA Pediatric Health and Diseases

MD. VEFA İSAYEVA

Liv Bona Dea Hospital Bakü
Spec. MD.  Elnur Hüseynov Pediatrics

Spec. MD. Elnur Hüseynov

Liv Bona Dea Hospital Bakü
Spec. MD. INARE ELDAROVA Pediatrics

Spec. MD. INARE ELDAROVA

Liv Bona Dea Hospital Bakü
Spec. MD. SADİQ İSMAYILOV Pediatric Health and Diseases

Spec. MD. SADİQ İSMAYILOV

Liv Bona Dea Hospital Bakü
MD. Dr. Elnur Hüseynov Pediatrics

MD. Dr. Elnur Hüseynov

Spec. MD. Doğa Sevinçok Pediatric and Adolescent Psychiatry

Spec. MD. Doğa Sevinçok

Pediatrics

Spec. MD. Sadık İsmayılov

Related Videos

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 67 91